← Evidence map

ArticleEmerging microbes & infections2022

Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.

Xijing Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35249454